Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Plos Pathogens
|
February 6, 2025
Activating PKC-ε induces HIV expression with improved tolerability
Alivelu M Irrinki, Jasmine Kaur, Bally Randhawa, et al.
Journal of Virology
|
September 8, 2017
HLA-B*14:02-Restricted Env-Specific CD8<sup>+</sup> T-Cell Activity Has Highly Potent Antiviral Efficacy Associated with Immune Control of HIV Infection
Ellen M Leitman, Christian B Willberg, Ming-Han Tsai, et al.
JCI Insight
|
February 8, 2024
Predictors of HIV rebound differ by timing of antiretroviral therapy initiation
Jonathan Z Li, Meghan Melberg, Autumn Kittilson, et al.
Gene Therapy
|
September 8, 2021
Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)
Jennifer E Adair, Lindsay Androski, Lois Bayigga, et al.
American Journal of Epidemiology
|
August 5, 2011
Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america
Alison G Abraham, Bryan Lau, Steven Deeks, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 29, 2012
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis
Amy C Justice, Sharada P Modur, Janet P Tate, et al.
Immunity
|
March 21, 2026
Multiomic analysis of ART-interruption cohorts identifies cell-extrinsic and -intrinsic mechanisms driving lymphocyte-mediated control of HIV rebound
Tongcui Ma, Ashley F George, Zichong Li, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Plos Pathogens
|
February 6, 2025
Activating PKC-ε induces HIV expression with improved tolerability
Alivelu M Irrinki, Jasmine Kaur, Bally Randhawa, et al.
Journal of Virology
|
September 8, 2017
HLA-B*14:02-Restricted Env-Specific CD8<sup>+</sup> T-Cell Activity Has Highly Potent Antiviral Efficacy Associated with Immune Control of HIV Infection
Ellen M Leitman, Christian B Willberg, Ming-Han Tsai, et al.
JCI Insight
|
February 8, 2024
Predictors of HIV rebound differ by timing of antiretroviral therapy initiation
Jonathan Z Li, Meghan Melberg, Autumn Kittilson, et al.
Gene Therapy
|
September 8, 2021
Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)
Jennifer E Adair, Lindsay Androski, Lois Bayigga, et al.
American Journal of Epidemiology
|
August 5, 2011
Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america
Alison G Abraham, Bryan Lau, Steven Deeks, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 29, 2012
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis
Amy C Justice, Sharada P Modur, Janet P Tate, et al.
Immunity
|
March 21, 2026
Multiomic analysis of ART-interruption cohorts identifies cell-extrinsic and -intrinsic mechanisms driving lymphocyte-mediated control of HIV rebound
Tongcui Ma, Ashley F George, Zichong Li, et al.
Page
of 5